Scarica l'app Stockscreener
0.338
6.11%
-0.022
Dopo l'orario di chiusura:
.35
0.012
+3.55%
Precedente Chiudi:
$0.36
Aprire:
$0.3425
Volume 24 ore:
516.50K
Relative Volume:
0.04
Capitalizzazione di mercato:
$5.51M
Reddito:
$456.00K
Utile/perdita netta:
$-20.64M
Rapporto P/E:
-0.139
EPS:
-2.4315
Flusso di cassa netto:
$-5.85M
1 W Prestazione:
-8.65%
1M Prestazione:
-32.48%
6M Prestazione:
-84.57%
1 anno Prestazione:
-84.21%
Intervallo 1D:
$0.3275
$0.3588
Intervallo di 1 settimana:
$0.3275
$0.491
Portata 52W:
$0.162
$2.8752
Mangoceuticals Inc Stock (MGRX) Company Profile
Nome
Mangoceuticals Inc
Settore
Industria
Telefono
(833) 626-4679
Indirizzo
15110 DALLAS PKWY, SUITE 600, DALLAS
Compare MGRX vs VEEV, TEM, BTSG, HQY, WAY
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
MGRX
Mangoceuticals Inc
|
0.338 | 5.51M | 456.00K | -20.64M | -5.85M | -2.4315 |
VEEV
Veeva Systems Inc
|
173.98 | 28.42B | 3.20B | 908.91M | 1.39B | 5.4168 |
TEM
Tempus Ai Inc
|
47.39 | 8.47B | 1.27B | -245.03M | -245.36M | -1.4071 |
BTSG
Brightspring Health Services Inc
|
43.10 | 8.28B | 12.91B | 104.80M | 394.69M | 0.8769 |
HQY
Healthequity Inc
|
84.67 | 7.15B | 1.31B | 215.20M | 408.32M | 2.4627 |
WAY
Waystar Holding Corp
|
23.74 | 4.55B | 1.10B | 112.09M | 283.19M | 0.6096 |
Mangoceuticals Inc Borsa (MGRX) Ultime notizie
Institution Moves: Will Mangoceuticals Inc benefit from seasonality2026 Big Picture & Weekly Consistent Profit Watchlists - baoquankhu1.vn
Securities.io - Securities.io
MGRX Stock Price, Quote & Chart | MANGOCEUTICALS INC (NASDAQ:MGRX) - ChartMill
MGRX: 2025 net loss widened to $20.6M on $456K revenue, with ongoing funding and dilution risks - TradingView
Mangoceuticals, Inc. (MGRX) 2025 Annual Report – Financials, Equity, and Consulting Agreements Overview - Minichart
Mangoceuticals 10-K: Revenue $0.456M, EPS loss $(2.17) - TradingView
Mangoceuticals (NASDAQ: MGRX) details 1-for-15 reverse split and $100M Solana treasury vision - Stock Titan
Mangoceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - MarketScreener
MGRX Q4 2025 Earnings Report on 4/1/2026 - MarketBeat
Mangoceuticals Delays Annual 10-K Yearly Filing - TipRanks
Mangoceuticals stock doubles after Texas lawsuit - MSN
MGRX SEC FilingsMangoceuticals, Inc. 10-K, 10-Q, 8-K Forms - Stock Titan
Why Faraday Future Intelligent Electric shares are trading higher by around 55%; here are 20 stocks moving premarket - MSN
Risks Report: How does Mangoceuticals Inc perform in inflationary periods2026 Patterns & Smart Money Movement Tracker - baoquankhu1.vn
MGRX Mangoceuticals (NASDAQ) pre-market +99.81% Mar 24, 2026: watch heavy volume - Meyka
Mag Mile Capital (OTCQB: MMCP) Surges 365% as CRE Financing Pipeline Expands Across Key Sectors - MarketScreener
Mangoceuticals (MGRX) Stock Rockets 130% Following CEO’s Substantial Share Award - mexc.com
Mangoceuticals (MGRX) Stock Surges 130% After CEO Lands 500K Share Bonus - MEXC Exchange
Mangoceuticals Inc (MGRX) Stock Price, Quote, News & History - Benzinga
Mangoceuticals Stock Doubles After Texas Lawsuit - Benzinga
Why Is Mangoceuticals, Inc. Stock (MGRX) Up Today? - TipRanks
$Mangoceuticals (MGRX.US)$ Locked and Loaded…LG…🏎👍🏿🔥🔥🔥🔥🔥🔥🔥🏁 - Moomoo
Setup Watch: Is Mangoceuticals Inc a good ESG investmentShare Buyback & Growth Oriented Trading Recommendations - baoquankhu1.vn
Layoff Watch: Can Mangoceuticals Inc ride the EV waveWeekly Investment Recap & Free Technical Confirmation Trade Alerts - baoquankhu1.vn
Mangoceuticals stock skyrockets 50% Friday: What's driving the rally? - MSN
Mangoceuticals (MGRX) CEO gets 2M options, bonus shares and trust note deal - Stock Titan
Mangoceuticals (MGRX) reprices CEO Jacob Cohen stock options to $0.45 - stocktitan.net
MGRX Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Mangoceuticals files $73 million lawsuit against tech vendor By Investing.com - Investing.com South Africa
Mangoceuticals files civil lawsuit against Clarity Ventures - TipRanks
Mangoceuticals Files $73 Million Lawsuit Against Clarity Ventures Over Alleged Contract Breach - geneonline.com
Mangoceuticals Sues Former Tech Partner Over Platform Dispute - TipRanks
Mangoceuticals announces lawsuit seeking damages exceeding $73 million against Clarity Ventures - marketscreener.com
Mangoceuticals files $73 million lawsuit against tech vendor - Investing.com
Mangoceuticals Announces Lawsuit Seeking Damages Exceeding $73 Million Against Clarity Ventures - TradingView
Mangoceuticals Announces Lawsuit Seeking Damages Exceeding $73 Million Against Former Technology Consulting and Software Development Firm, Clarity Ventures, Inc. - The Manila Times
Jacob Cohen option repricing at Mango - TradingView
Mangoceuticals (NASDAQ: MGRX) reprices CEO options and pursues $73M Clarity lawsuit - Stock Titan
Mangoceuticals Announces Lawsuit Seeking Damages Exceeding - GlobeNewswire
Mangoceuticals plunges after denying Lilly, Novo partnerships - MSN
Mangoceuticals files to sell 4.46M shares of common stock by selling shareholders - MSN
Mangoceuticals stock surges on early success of subscription TRT model - MSN
Merger Talk: Is Mangoceuticals Inc stock a top performer YTD2026 Retail Activity & Growth Oriented Trading Recommendations - baoquankhu1.vn
Aug Breakouts: Can Mangoceuticals Inc ride the EV wave2026 Earnings Surprises & Weekly High Return Stock Opportunities - baoquankhu1.vn
MGRX PE Ratio & Valuation, Is MGRX Overvalued - Intellectia AI
Mangoceuticals, Cube Group partner for up to $100M Solana-focused DAT strategy - MSN
Analyst Downgrade: Can Mangoceuticals Inc expand into new marketsEarnings Recap Report & Reliable Volume Spike Alerts - baoquankhu1.vn
Mangoceuticals, Inc. Files International Patent Application for Innovative Antiviral Feed Additive Technology MGX-0024 - Quiver Quantitative
Mangoceuticals, Inc. announces percent patent filing for MGX-0024 antiviral technology to include inhibiting respiratory or orally acquired virus infection in animals or birds - marketscreener.com
Mangoceuticals, Inc. Announces Pct Patent Filing for Mgx-0024 Antiviral Technology - marketscreener.com
Zero respiratory deaths in 29,000 birds sparks global patent bid - Stock Titan
Mangoceuticals Inc Azioni (MGRX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.66%
3.25%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):